FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3039888522> ?p ?o ?g. }

• W3039888522 endingPage "82" @default.
• W3039888522 startingPage "71" @default.
• W3039888522 abstract "Graft versus host” disease (GvHD) is one of the most frequent and severe complications of allogeneic hematopoietic stem cell transplantation (allo-HSCT). The optimal model of GvHD prophylaxis in allo-HSCT from alternative donors in children currently remains actual question. Materials and methods. The study was approved by the Independent Ethics Committee and the Scientific Council of the N.N. Blokhin National Medical Research Center of Oncology, Ministry of Healthcare of Russian Federation. Two hundred fifty six allo-HSCT were made during the period 2003–2019 from matched unrelated donors (MUD). Age median was 7.1 years old. The source of hematopoietic stem cells (HSCs) bone marrow – 76% (n = 194), peripheral blood stem cells – 24% (n = 62). GvHD prophylaxis included: tacrolimus (Tacro), cyclosporin A (CsA), methotrexate (Mtx), mycophenolate mofetil (MMF), in following combinations Tacro/Mtx (n = 98), Tacro/MMF (n = 102), tacro/Mtx + MMF (n = 3), CsA/Mtx (n = 24), CsA/Mtx + MMF (n = 12), CsA + MMF (n = 14). Median follow-up 8.9 years. GvHD prophylaxis regimen did not affect significantly the toxicity of therapy (toxicity: severe mucositis grade III–IV, nephrotoxicity, hepatotoxicity) (p = 0.4; p = 0.24; p = 0.62 respectively). In our study the rate of the overall survival (ОS) has significant differences in depending of the source of prevention GvHD. The using a combination of tacrolimus and cyclosporine with low doses of methotrexate had a positive effect on OS (p = 0.035) in patients of common non-malignant and malignant groups, as well as on the level of 2-year relapse-free survival in the group of children with malignant disorders (p = 0.671). In the general group the OS the worst results were achieved when MMF was included in the prophylaxis model. In this experience of treating of a large cohort of patients the choice of calcineurin inhibitors and methotrexate as the agent GvHD prophylaxis showed the efficacy and safety for non-manipulated MUD for both malignant and non-malignant diseases in children." @default.
• W3039888522 created "2020-07-10" @default.
• W3039888522 creator A5024728650 @default.
• W3039888522 creator A5041371660 @default.
• W3039888522 creator A5052697557 @default.
• W3039888522 creator A5064603297 @default.
• W3039888522 creator A5065631691 @default.
• W3039888522 creator A5071966994 @default.
• W3039888522 creator A5077754985 @default.
• W3039888522 creator A5079886921 @default.
• W3039888522 creator A5080383670 @default.
• W3039888522 date "2020-07-02" @default.
• W3039888522 modified "2023-10-01" @default.
• W3039888522 title "The efficacy of the regimens of “graft versus host” disease prophylaxis after hematopoietic stem cell transplantation from unrelated donors in children: single center experience" @default.
• W3039888522 cites W114565271 @default.
• W3039888522 cites W1790218080 @default.
• W3039888522 cites W1965249571 @default.
• W3039888522 cites W1970109840 @default.
• W3039888522 cites W1977086270 @default.
• W3039888522 cites W1979019278 @default.
• W3039888522 cites W1980288572 @default.
• W3039888522 cites W1983909997 @default.
• W3039888522 cites W1999406314 @default.
• W3039888522 cites W2034208644 @default.
• W3039888522 cites W2044560944 @default.
• W3039888522 cites W2052605694 @default.
• W3039888522 cites W2068573750 @default.
• W3039888522 cites W2107730066 @default.
• W3039888522 cites W2109285747 @default.
• W3039888522 cites W2114077193 @default.
• W3039888522 cites W2115896858 @default.
• W3039888522 cites W2126021331 @default.
• W3039888522 cites W2127660435 @default.
• W3039888522 cites W2167596167 @default.
• W3039888522 cites W2169721813 @default.
• W3039888522 cites W2265471938 @default.
• W3039888522 cites W2267509827 @default.
• W3039888522 cites W2305401873 @default.
• W3039888522 cites W2336931112 @default.
• W3039888522 cites W2337969406 @default.
• W3039888522 cites W2416050694 @default.
• W3039888522 cites W2460871005 @default.
• W3039888522 cites W2493042425 @default.
• W3039888522 cites W2605507331 @default.
• W3039888522 cites W2618073389 @default.
• W3039888522 cites W2621546725 @default.
• W3039888522 cites W2730772122 @default.
• W3039888522 cites W2736201657 @default.
• W3039888522 cites W2769990542 @default.
• W3039888522 cites W2770831277 @default.
• W3039888522 cites W2901233842 @default.
• W3039888522 cites W2908023643 @default.
• W3039888522 cites W2914352789 @default.
• W3039888522 cites W2952168165 @default.
• W3039888522 cites W2981089741 @default.
• W3039888522 cites W3009922214 @default.
• W3039888522 cites W315558393 @default.
• W3039888522 doi "https://doi.org/10.24287/1726-1708-2020-19-2-71-82" @default.
• W3039888522 hasPublicationYear "2020" @default.
• W3039888522 type Work @default.
• W3039888522 sameAs 3039888522 @default.
• W3039888522 citedByCount "0" @default.
• W3039888522 crossrefType "journal-article" @default.
• W3039888522 hasAuthorship W3039888522A5024728650 @default.
• W3039888522 hasAuthorship W3039888522A5041371660 @default.
• W3039888522 hasAuthorship W3039888522A5052697557 @default.
• W3039888522 hasAuthorship W3039888522A5064603297 @default.
• W3039888522 hasAuthorship W3039888522A5065631691 @default.
• W3039888522 hasAuthorship W3039888522A5071966994 @default.
• W3039888522 hasAuthorship W3039888522A5077754985 @default.
• W3039888522 hasAuthorship W3039888522A5079886921 @default.
• W3039888522 hasAuthorship W3039888522A5080383670 @default.
• W3039888522 hasBestOaLocation W30398885221 @default.
• W3039888522 hasConcept C126322002 @default.
• W3039888522 hasConcept C141071460 @default.
• W3039888522 hasConcept C2777408962 @default.
• W3039888522 hasConcept C2778496288 @default.
• W3039888522 hasConcept C2779972918 @default.
• W3039888522 hasConcept C2781059491 @default.
• W3039888522 hasConcept C2781413609 @default.
• W3039888522 hasConcept C2909675724 @default.
• W3039888522 hasConcept C2911091166 @default.
• W3039888522 hasConcept C29730261 @default.
• W3039888522 hasConcept C71924100 @default.
• W3039888522 hasConcept C90924648 @default.
• W3039888522 hasConceptScore W3039888522C126322002 @default.
• W3039888522 hasConceptScore W3039888522C141071460 @default.
• W3039888522 hasConceptScore W3039888522C2777408962 @default.
• W3039888522 hasConceptScore W3039888522C2778496288 @default.
• W3039888522 hasConceptScore W3039888522C2779972918 @default.
• W3039888522 hasConceptScore W3039888522C2781059491 @default.
• W3039888522 hasConceptScore W3039888522C2781413609 @default.
• W3039888522 hasConceptScore W3039888522C2909675724 @default.
• W3039888522 hasConceptScore W3039888522C2911091166 @default.
• W3039888522 hasConceptScore W3039888522C29730261 @default.
• W3039888522 hasConceptScore W3039888522C71924100 @default.
• W3039888522 hasConceptScore W3039888522C90924648 @default.
• W3039888522 hasIssue "2" @default.

• next